Michelle Harkness
About Michelle Harkness
Michelle Harkness is the Associate Director of DEA Operations at Bristol-Myers Squibb, with over 25 years of experience in compliance and operations within the pharmaceutical industry.
Company
Michelle Harkness is currently an Associate Director of DEA Operations at Bristol-Myers Squibb. She has been with the company for over two decades, establishing a strong commitment and leveraging a vast range of expertise within compliance and operations. Her role at Bristol-Myers Squibb emphasizes ensuring regulatory compliance and maintaining operational efficiency.
Title
After holding various roles aimed at auditing and compliance, Michelle Harkness now serves as the Associate Director of DEA Operations at Bristol-Myers Squibb. In this capacity, she plays a key role in overseeing DEA regulatory compliance and the efficiency of operational processes.
Education and Expertise
Michelle Harkness holds a Bachelor of Science degree from The College of New Jersey. She possesses over 25 years of experience in the pharmaceutical industry, with a strong focus on compliance and operations. Her extensive background includes roles in technical writing, laboratory research, and auditing, which have equipped her with a diverse skill set.
Background
Michelle Harkness started her career as a Research Laboratory Technician at FMC Corporation in 1993 before transitioning to a role as a Technical Writer. She continued to expand her expertise within the company before moving to Bristol-Myers Squibb in 1998. At Bristol-Myers Squibb, she held roles such as Compliance Auditor, Senior Compliance Auditor, and Manager DEA Operations, before advancing to her current position.
Career at Bristol-Myers Squibb
Throughout her tenure at Bristol-Myers Squibb, Michelle Harkness has progressed from being a Compliance Auditor to her current role as Associate Director DEA Operations. Her career at the company includes significant periods as a Senior Compliance Auditor (2001-2005), Manager DEA Operations (2005-2017), and her current position which she has held since 2017. Her long-term dedication and evolution through these roles underscore her depth of experience and expertise in compliance and operations.